Max Robotics — Global Service Robot Directory + US Certification

About

Sara Broggi is a leading researcher in radiation oncology, with a primary focus on advancing ultra-hypofractionated radiotherapy for prostate cancer. Her major contribution lies in pioneering the PRO-FAST protocol—a comprehensive, single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT approach that compresses the entire treatment course into a single day. This breakthrough challenges conventional multi-week regimens, aiming to reduce patient burden while maintaining high efficacy. Although her most-cited paper from 2025 has garnered 1 citation to date, its innovative framework is poised to shape future clinical trials and practice. Broggi’s work addresses a critical gap in the literature, where very few studies have explored single-fraction strategies for prostate cancer. Her research underscores a commitment to improving patient quality of life through shorter, more precise treatments, making her a notable figure in the evolution of stereotactic body radiotherapy. For students and researchers, Broggi exemplifies how targeted, hypothesis-driven work can push the boundaries of oncological care.